Early Mortality of Prostatectomy vs. Radiotherapy as a Primary Treatment for Prostate Cancer: A Population-Based Study From the United States and East Germany
By Medenwald D, Vordermark D, Dietzel CT (2020). Front. Oncol. 11:635433. doi: 10.3389/fonc.2019.01451
In the original article, there was a mistake in Figure 1 as published. The color shade of the Kaplan-Meier survival curves was confused between the group with surgery and radiotherapy for the US data. The corrected Figure 1 appears below.
Figure 1 Kaplan–Meier (A) comparing surgery vs. radiotherapy (radiotherapy = reference) and (B) hazard survival plot of prostate cancer patients from German and US cancer registries. Lines indicate the year of diagnosis specific (2005–2013) conditional hazard for radiotherapy (risk to die in the following month, blue) and surgery (red) from Kaplan–Meier plots. Thick lines refer to the smoothed average of year-specific hazard in patients treated with radiotherapy and surgery, respectively.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: early mortality, prostate cancer, prostatectomy, radiotherapy, general population
Citation: Medenwald D, Vordermark D and Dietzel CT (2021) Corrigendum: Early Mortality of Prostatectomy vs. Radiotherapy as a Primary Treatment for Prostate Cancer: A Population-Based Study From the United States and East Germany. Front. Oncol. 11:635433. doi: 10.3389/fonc.2021.635433
Received: 14 December 2020; Accepted: 13 January 2021;
Published: 05 February 2021.
Edited and reviewed by: Mohamed Saad Zaghloul, Cairo University, Egypt
Copyright © 2021 Medenwald, Vordermark and Dietzel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Daniel Medenwald, RGFuaWVsLm1lZGVud2FsZEB1ay1oYWxsZS5kZQ==